Clinical Trials Logo

Clinical Trial Summary

The purpose of this study is to investigate the efficacy and safety of NT 201 injections in the treatment of enlarged pores and excessive sebum production in the face.


Clinical Trial Description

Eligible subjects will be randomized to one of the two treatment groups: NT 201 group and placebo in order to receive one session of injections with either NT 201 or placebo in the upper face (forehead and cheek area) on Day 1 and followed for about 90 days after treatment. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT05784363
Study type Interventional
Source Merz North America, Inc.
Contact
Status Active, not recruiting
Phase Phase 1
Start date October 27, 2022
Completion date August 2024

See also
  Status Clinical Trial Phase
Completed NCT05097157 - Study To Assess A Radiofrequency Microneedling Device For Dermatologic Conditions N/A
Completed NCT05254210 - Feasibility Study To Collect Safety And Preliminary Efficacy Data For A Radiofrequency Microneedling Device N/A
Recruiting NCT04471948 - The Safety and Efficacy of 1064-nm Picosecond Laser With Microlens Array for Pore Tightening; a Pilot Study N/A
Active, not recruiting NCT02544958 - Er:YAG Laser for Treatment of Enlarged Pores N/A
Recruiting NCT05987319 - Feasibility Study to Collect and Assess Safety Data for a Radiofrequency Microneedling Device for Electrocoagulation and Hemostasis of Soft Tissues for Dermatologic Conditions N/A
Active, not recruiting NCT06293755 - Microneedle Patch With Botulinum Toxin in Management of Enlarged Facial Pores Phase 3